Clinical Trials Logo

Clinical Trial Summary

The proposed project will tackle the two most salient problems for children under 5 in Brazil: the continued high rates of neonatal mortality, and the large disparities in early childhood development. We propose to extend and scale up previously tested and validated home visiting programs to the city of Boa Vista in the north region of Brazil. The core intervention of the program will be home visits or group meetings to mothers and caregivers by trained child development agents. At the core of the program is a detailed curriculum, which contains gestation and age-specific topics of child health and development to be discussed with caregivers at each encounter.


Clinical Trial Description

Even though much progress has been achieved in child mortality globally, relatively minor improvements have been realized in the first four weeks of children's life generally referred to as the neonatal period. Each year, four million infants die within the first 28 days of their life globally. As pointed out in the Lancet's neonatal survival series, 3 million neonatal deaths could be prevented each year by low-cost interventions. In Brazil, more than 25,000 newborns die each year within the first 28 days of their life, with a majority of deaths occurring in the first week. Previous studies suggest that one of the most effective ways to prevent such deaths are home visiting programs, which support mothers in the first weeks of infant's lives, promote breastfeeding and kangaroo mother care, and ensure appropriate medical care when needed. From a child health and child development perspective, optimal outcomes appear only feasible if continued support is provided to mothers from pregnancy throughout the first years of children's life. Home-based visits and support have become increasingly recognized as a both crucial and highly cost-effective strategy to achieve such outcomes.

The objective of this project is to extend and scale up the previously tested and validated home visiting programs to the city of Boa Vista. At the core of this program is a detailed curriculum, which contains gestation and age-specific topics of child health and development to be discussed with caregivers at each home visit. The intervention package will start in the third trimester of pregnancy and feature to sessions per month up to age 3 years.

This curriculum will be delivered through two separate - and randomly assigned - platforms: home visits through trained Child Development Agents (CDAs), and center-based delivery of the same delivery to groups of caregivers. The pilot study in Sao Paulo suggests that each CDA can handle approximately 40 families, visiting each caregiver twice per month. Visits will be initiated during the second trimester of pregnancy. The visits during pregnancy will not be a substitute for prenatal care but are designed to prepare mothers for babies and set up a relationship for a closer follow-up after birth. In Brazil, as well as globally, the numbers of pre-term deliveries and stillbirth is rather large, 20% of mature stillbirths (more than 37 weeks of gestation, more than 2.5 Kg) so the pre-natal care can be improved clearly. The visits would also occur during the neonatal period, when the largest proportional of under 5 mortality happens. This would be the first component of the program, addressing maternal and perinatal/neonatal mortality. Particular attention will be given to mothers after birth, with two special visits scheduled for the first week after birth focusing on maternal mental health; breastfeeding as well as kangaroo mother care when appropriate. Such visitation programs have been successfully tested within the family health strategy, and will be further reinforced and complemented by the new visitation program.

The city of Boa Vista has a population of approximately 330,000 people, with, 22,377 families (~30%) currently receiving social cash transfers under the bolsa familia program. The city is comparable to the national average in terms of the observed poverty rates, and roughly average in terms of its size. Infant mortality rate is estimated at 14.2 per 1000 live births, with 21% of births given by teenage mothers and 15% of infants born preterm.

The proposed project will exclusively target the most vulnerable households currently supported by the bolsa familia social cash transfer program. According to municipality estimates, about 5000 children are born each year in eligible households. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03386747
Study type Interventional
Source University of Sao Paulo
Contact
Status Enrolling by invitation
Phase N/A
Start date December 1, 2017
Completion date December 1, 2020

See also
  Status Clinical Trial Phase
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Not yet recruiting NCT04093778 - NEO-study, Newborn Emergency Outcome N/A
Active, not recruiting NCT03871491 - Azithromycin-Prevention in Labor Use Study (A-PLUS) Phase 3
Completed NCT03290924 - Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach N/A
Recruiting NCT05127070 - Evaluating the NeoTree in Malawi and Zimbabwe
Completed NCT02148952 - BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program N/A
Completed NCT03923023 - Impact of the PREEMI Package on Neonatal Mortality
Completed NCT03722615 - Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa
Completed NCT05369806 - Leveraging Interactive Text Messaging to Monitor and Support Maternal Health in Kenya N/A
Recruiting NCT03577054 - Development of a Mobile Application for HBB Prompt Study N/A
Active, not recruiting NCT05854745 - Comparison of Virtual Training to In-Person Training of Helping Babies Breathe in Ethiopia N/A
Recruiting NCT05763316 - Accuracy of Scoring Systems for Risk Assessment in Neonatal Intensive Care Unit
Recruiting NCT05714865 - Implementing LISA Surfactant in Nigeria Phase 4
Completed NCT01867749 - Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss N/A
Not yet recruiting NCT05763693 - Vitality in Infants Via Azithromycin for Neonates Trial Phase 4
Completed NCT03213509 - Verbal Autopsy of Maternal Deaths, Stillbirths, and Neonatal Deaths in BetterBirth
Active, not recruiting NCT03032276 - Safe Motherhood Promotion and Newborn Survival N/A
Enrolling by invitation NCT03438110 - Asia Pregnancy Outcomes Study
Completed NCT04311476 - Autologous Cord Blood Cells for Prevention of BPD in Preterm Phase 2
Completed NCT02999373 - Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates Phase 2